Therapeutic Vision, Inc. is a small company that is focused on the development of pharmaceuticals primarily for the companion animal market and eventually their owners. We are developing age-related and diabetic therapies for the preservation of vision and the prevention of neurodegeneration.
Therapeutic Vision, Inc. (TVI)
Therapeutic Vision strives to provide you with cutting edge medications to maintain your pet’s vision.
Our research team with vision research and veterinary ophthalmology expertise are developing drugs to preserve the vision of your aging and diabetic patients that are backed with strong experimental evidence.
Kinostat® is currently not available for sale. We are in the process of filing paperwork required for FDA approval which is estimated to be near the end of 2017. Thank you for your interest in our product. We are striving to make this available as soon as possible to meet you diabetic dog’s needs.
- 9/1/2015 TVI has received an SBIR Phase 2B grant from the National Eye Institute to develop Kinostat®.
- 9/17/15 TVI received a Business innovation Award from the NE Dept. of Economic Development to develop Kinostat.
- 11/2015 TVI inventors received approval from the US Patent Office for the use of Kinostat in both animals and humans.
- 3/3/16 TVI has been chosen by the SBIR Office of the National Institutes of Health to be showcased in the Innovation Zone for the 2016 BIO International Convention to be held in San Francisco, June 6-9, 2016.